Unnamed: 0,title,date,stock,sentiment
289733.0,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",2020-06-04 08:13:00-04:00,CPIX,positive
289734.0,"The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer",2020-05-28 08:24:00-04:00,CPIX,neutral
289735.0,Stocks That Hit 52-Week Lows On Wednesday,2020-05-27 10:44:00-04:00,CPIX,negative
289736.0,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas",2020-05-27 07:25:00-04:00,CPIX,positive
289737.0,33 Stocks Moving in Wednesday's Pre-Market Session,2020-05-27 07:19:00-04:00,CPIX,neutral
289738.0,"Cumberland Q1 Adj. EPS $0.010 Misses $0.020 Estimate, Sales $9.100M Miss $9.460M Estimate",2020-05-20 16:10:00-04:00,CPIX,negative
289739.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,CPIX,neutral
289740.0,Cumberland Pharma Reports Initiative To Increase Availability Of Vaprisol ?Injection For Treating Hyponatermia Associated With Critical Care Patients During Coronavirus Pandemic,2020-04-07 17:01:00-04:00,CPIX,positive
289741.0,"Cumberland Pharma Highlights National Initiative To Support Hospitals, Clinics Using Caldolor Injection For Treatment Of Patients With Fever, Hyperthermia, Other Symptoms Associated With Coronavirus Infection",2020-03-31 17:05:00-04:00,CPIX,positive
289742.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,CPIX,negative
289743.0,Cumberland Pharmaceuticals Announces Initiative To 'Expand Availability' Of VIBATIV To Treat ospital-Acquired & Ventilator-ASsociated Pneumonia,2020-03-23 17:02:00-04:00,CPIX,positive
289744.0,"Cumberland Q4 Adj. EPS $0.09 Beats $0.01 Estimate, Sales $13.7M Beat $11.34M Estimate",2020-03-18 16:08:00-04:00,CPIX,neutral
289745.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,CPIX,positive
289746.0,"Earnings Scheduled For March 18, 2020",2020-03-18 04:24:00-04:00,CPIX,neutral
289747.0,"The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review",2020-03-15 09:55:00-04:00,CPIX,neutral
289748.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,CPIX,positive
289749.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,CPIX,negative
289750.0,Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results To Wed. Mar. 18 After The Close,2020-03-06 16:35:00-05:00,CPIX,neutral
289751.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,CPIX,negative
289752.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,CPIX,neutral
289753.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,CPIX,positive
289754.0,Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product,2020-01-07 16:11:00-05:00,CPIX,neutral
289755.0,"B. Riley Maintains Buy on Cumberland, Raises Price Target to $9.75",2019-12-03 09:14:00-05:00,CPIX,neutral
289756.0,Cumberland Pharma Recieves FDA Approval of its RediTrex,2019-12-02 08:03:00-05:00,CPIX,positive
289757.0,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",2019-11-22 08:18:00-05:00,CPIX,positive
289758.0,Stocks That Hit 52-Week Lows On Thursday,2019-11-21 11:09:00-05:00,CPIX,negative
289759.0,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout",2019-11-19 07:56:00-05:00,CPIX,neutral
289760.0,"B. Riley FBR Maintains Buy on Cumberland, Lowers Price Target to $9",2019-11-18 11:00:00-05:00,CPIX,negative
289761.0,"Cumberland Q3 EPS $(0.13) Misses $0.11 Estimate, Sales $10.4M Miss $12.65M Estimate",2019-11-12 16:22:00-05:00,CPIX,negative
289762.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,CPIX,neutral
289763.0,UPDATE: Cumberland Awarded $1M+ In Funding From FDA Through Orphan Drug Grant Program,2019-09-24 09:35:00-04:00,CPIX,positive
289764.0,Cumberland Pharma Reports FDA Orphan Drug Grant Award For New Phase 2 Clinical Program,2019-09-24 09:35:00-04:00,CPIX,positive
289765.0,"UPDATE: Cumberland Says FDA 'recommended splitting up the submission into several separate submissions, each containing a single proposed labeling claim or group of related labeling claims, with additional data...'",2019-09-10 17:27:00-04:00,CPIX,positive
289766.0,Cumberland Pharma 8-K Shows FDA Informed Co. Submission For Caldolor New Drug Application Approval Was Not Accepted For Review Because 'A Number Of New Claims',2019-09-10 17:27:00-04:00,CPIX,positive
289767.0,Stocks That Hit 52-Week Lows On Wednesday,2019-09-04 11:39:00-04:00,CPIX,negative
289768.0,"The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books",2019-09-04 07:08:00-04:00,CPIX,positive
289769.0,"The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings",2019-08-29 07:38:00-04:00,CPIX,negative
289770.0,"Cumberland Q2 EPS $0.1 Beats $0.07 Estimate, Sales $11.581M Miss $12.59M Estimate",2019-08-14 17:10:00-04:00,CPIX,negative
289771.0,Q2 Earnings Preview For Cumberland,2019-08-14 07:24:00-04:00,CPIX,neutral
289772.0,Cumberland Pharma Signs Exclusive License Deal For Distribution In China,2019-05-15 09:35:00-04:00,CPIX,positive
289773.0,Cumberland Pharmaceuticals Says Has Reached Agreement With Hong Kong WinHealth Pharmaceuticals,2019-05-14 16:48:00-04:00,CPIX,positive
289774.0,"Cumberland Q1 EPS $0.11 Beats $(0.11) Estimate, Sales $11.9M Beat $10.7M Estimate",2019-05-14 16:20:00-04:00,CPIX,neutral
289775.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,CPIX,positive
289776.0,"Earnings Scheduled For May 14, 2019",2019-05-14 04:57:00-04:00,CPIX,neutral
289777.0,30 Stocks Moving In Monday's Mid-Day Session,2019-05-06 12:23:00-04:00,CPIX,neutral
289778.0,Cumberland Pharma Reports Strategic Review,2019-03-29 10:42:00-04:00,CPIX,neutral
289779.0,"Cumberland Q4 EPS $0.10 Beats $(0.16) Estimate, Sales $13.5M Beat $10.98M Estimate",2019-02-26 16:41:00-05:00,CPIX,neutral
289780.0,Cumberland Pharma 8-K Shows Co. Received Notice Of Approval From FDA For Application Related To Next-Gen Caldolor,2019-01-28 17:30:00-05:00,CPIX,positive
289781.0,Cumberland Pharmaceuticals Receives FDA Notification Setting Sept 2019 As PDUFA Action Date For Approval Decision Regarding NDA For Methotrexate Product Line; Remitted Payment Of $1.3M To FDA For PDUFA Application Fee Associated With Methotrexate,2019-01-24 17:40:00-05:00,CPIX,positive
289782.0,Cumberland Pharmaceuticals Says On Jan 4 FDA Accepted For Review NDA For Approval Of Methotrexate Product Line; Projected PDUFA Date for November 2018,2019-01-14 06:19:00-05:00,CPIX,positive
289783.0,"Cumberland Pharmaceuticals Inc. Q3 EPS $(0.05) Down From $0.01 YoY, Sales $8.493M Miss $9.16M Estimate",2018-11-13 16:41:00-05:00,CPIX,negative
289784.0,"Cumberland Pharma To Purchase VIBATIV From Theravance Biopharma For $20M Plus $5M In Added Payment In Early 2019, Tiered Royalties Of Up To 20% On Future US Net Product Sales",2018-11-06 08:33:00-05:00,CPIX,neutral
289785.0,Cumberland Pharma Shares Halted News Pending,2018-11-06 08:30:00-05:00,CPIX,positive
289786.0,"Stocks Which Set New 52-Week Low Yesterday, October 23rd",2018-10-24 10:06:00-04:00,CPIX,negative
289787.0,Cumberland Pharmaceuticals Submitted An Amendment To Application For Approval Of Caldolor (ibuprofen) Injection Product And Will Await FDA's Response Decision; NOTE: Co. On Aug. 2 Received CRL Outlining Additional Information Needed For Caldolor Approval,2018-10-01 17:41:00-04:00,CPIX,positive
289788.0,Cumberland Pharma Reports Study Results Published In 'Lung Cancer: Targets And Therapy' Showed 'subcutaneous amifostine administered before radiotherapy postponed the onset of acute esophagitis in stage 3 small cell lung cancer patients...',2018-09-27 09:04:00-04:00,CPIX,negative
289789.0,"Cumberland Q2 Adj. EPS $0.01 Beats $(0.08) Estimate, Sales $10.164M Beat $9.94M Estimate",2018-08-14 17:17:00-04:00,CPIX,neutral
289790.0,"Stocks Which Set New 52-Week Low Yesterday, August 7th",2018-08-08 11:06:00-04:00,CPIX,negative
289791.0,UPDATE: Cumberland Q1 Adj. EPS $(0.09),2018-05-08 16:50:00-04:00,CPIX,neutral
289792.0,"Cumberland Q1 EPS $(0.15) Misses $(0.02) Estimate, Sales $8.58M Miss $9.71M Estimate",2018-05-08 16:50:00-04:00,CPIX,negative
289793.0,"B. Riley Initiates Coverage On Cumberland with Buy Rating, Announces $9.25 Price Target",2018-04-17 09:11:00-04:00,CPIX,neutral
289794.0,Cumberland Pharmaceuticals Reports Newly Published Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients,2018-01-30 09:40:00-05:00,CPIX,neutral
289795.0,"Cumberland Pharma Reports Q3 EPS $(0.05) vs. $0.01 In Same Qtr. Last Year, Sales $11.2M vs. $8.8M YoY",2017-11-07 16:28:00-05:00,CPIX,neutral
289796.0,"Cumberland Pharma Reports Q2 Adj. Loss/Share $(0.05) vs. $0.04 EPS In Same Qtr. Last Year, Sales $8.7M vs. $7.4M YoY",2017-08-08 17:07:00-04:00,CPIX,neutral
289797.0,Cumberland Pharmaceuticals Initiates U.S. Shipments Of Dexrazoxane For Oncology Patient Support,2017-07-31 08:24:00-04:00,CPIX,positive
289798.0,"Cumberland Pharmaceuticals Reports Q1 Adj. EPS $(0.02), Flat vs Same Qtr. Last Year, Sales $9.6M vs $7.7M YoY",2017-05-15 16:51:00-04:00,CPIX,neutral
289799.0,Cumberland Pharma to Partner with Poly Pharma for Kristalose in the US,2017-04-26 08:06:00-04:00,CPIX,neutral
289800.0,"Cumberland Pharma Reports Publication Of A Trial Providing Evidence Its Caldolor Improves Postoperative Pain, Decreases Opioid Use",2017-03-27 16:18:00-04:00,CPIX,negative
289801.0,"Cumberland Pharma Reports Q4 EPS $(0.05) vs $0.01 in Same Qtr. Last Year, Sales $9.081M vs $8.037M YoY",2017-03-07 16:20:00-05:00,CPIX,neutral
289802.0,U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case For Acetadote Product,2017-01-30 08:15:00-05:00,CPIX,negative
289803.0,U.S. Appeals Court Rules In Favor of Cumberland Pharmaceuticals Over Mylan In Patent Dispute Realted To Acetadote,2017-01-26 09:27:00-05:00,CPIX,neutral
289804.0,Cumberland Pharma and Clinigen Enter Exclusive US Commercialization Agreement for Totect,2017-01-09 09:31:00-05:00,CPIX,positive
289805.0,"Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products, Terms Not Disclosed",2016-11-16 08:02:00-05:00,CPIX,neutral
289806.0,"Cumberland Pharmaceuticals Reports Q3 Adj EPS $0.06, Revenues $8.8M",2016-11-01 17:34:00-04:00,CPIX,neutral
289807.0,Cumberland Pharmaceuticals Launches Promotion Of Ethyol In The United States For Oncology Patient Support,2016-09-26 08:32:00-04:00,CPIX,positive
289808.0,"Cumberland Pharmaceuticals Announces New Program To Develop Portaban For Portal Hypertension, FDA Clears Investigational New Drug Submission",2016-09-14 16:06:00-04:00,CPIX,positive
289809.0,Cumberland Pharma Reports Commencement of US Shipments of Ethyol for Oncology Patient Support,2016-08-23 16:07:00-04:00,CPIX,positive
289810.0,"Cumberland Pharmaceuticals Reports Q2 EPS $0.04 vs. Prior Year Quarter $0.09, Rev. $7.4M vs. Prior Year Quarter $8.9M",2016-08-02 17:17:00-04:00,CPIX,neutral
289811.0,"Cumberland Pharmaceuticals Reports Q1 EPS $(0.02) vs. Prior Year Quarter $0.00, Rev. $7.737M vs. Prior Year Quarter $8.68M",2016-05-10 16:12:00-04:00,CPIX,neutral
289812.0,"Cumberland Pharmaceuticals, Clinigen Group enter into exclusive U.S. commercialization agreement for oncology support drug Ethyol",2016-05-10 07:11:00-04:00,CPIX,positive
289813.0,"Cumberland Pharmaceuticals Reports New Program To Develop Vasculan For Systemic Sclerosis, FDA Clears IND Submission and Phase II Study Initiated",2016-04-27 08:05:00-04:00,CPIX,positive
289814.0,"Cumberland Pharma Reports Launch of Caldolor for Treatment of Pain, Fever in Children",2016-03-24 07:31:00-04:00,CPIX,negative
289815.0,"Cumberland Pharmaceuticals Reports Q4 EPS $0.03 vs. Prior Year Quarter $0.10, REv. $8M vs. Prior Year Quarter $9.3M",2016-03-03 16:09:00-05:00,CPIX,neutral
289816.0,Caldolor Approved For Use In Pediatric Patients,2015-11-23 09:27:00-05:00,CPIX,positive
289817.0,Cumberland Pharmaceuticals Announces Favorable Acetadote Patent Ruling,2015-11-20 09:21:00-05:00,CPIX,positive
289818.0,"Cumberland Pharma Reports Q3 EPS $0.01, Sales $7.89M, no estimates",2015-11-03 16:08:00-05:00,CPIX,negative
289819.0,U.S. District Court Rules in Favor of Cumberland Pharmaceuticals in Lawsuit vs Mylan for Infringement of Co's 445 Acetadote Patent -8-K,2015-10-05 06:20:00-04:00,CPIX,negative
289820.0,Cumberland Pharma Reports Strategic Alliance with Clinigen Group to 'Maximize Commercial Potential of Future Products',2015-09-17 08:08:00-04:00,CPIX,neutral
289821.0,"Cumberland Pharmaceuticals Reports Q2 EPS $0.09, Estimates Not Available",2015-08-04 17:11:00-04:00,CPIX,neutral
289822.0,"Cumberland Pharma Reports Q2 EPS $0.02, Sales $8.91M, no estimates",2015-08-04 17:09:00-04:00,CPIX,negative
289823.0,Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Growth Forecast For Next 5 Years,2015-06-05 04:32:00-04:00,CPIX,positive
289824.0,"Cumberland Pharma Reports Q1 Adj. EPS $0.09, Sales $8.7M",2015-05-07 16:56:00-04:00,CPIX,neutral
289825.0,Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2015-05-07 04:51:00-04:00,CPIX,negative
289826.0,Cumberland Pharma Reports Q4 Adj. EPS $0.10,2015-03-03 16:09:00-05:00,CPIX,neutral
289827.0,Cumberland Pharmaceuticals Announces Pipeline Expansion With Boxaban,2015-02-11 08:06:00-05:00,CPIX,neutral
289828.0,Cumberland Reports Phase IV Studies Published Supporting Safety of Shortened Infusion Time of Caldolor Injection,2015-02-02 08:36:00-05:00,CPIX,positive
289829.0,"Cumberland Pharmaceuticals Inc. Reports Q3 EPS of $0.04, Down 20% YOY; Revenue of $9.70M, Down 5% YOY",2014-11-04 16:21:00-05:00,CPIX,neutral
289830.0,"Cumberland Pharmaceuticals Inc. Reports Q1 EPS of $0.02, Down 60% YOY; Revenue of $8.09M, Down 21% YOY",2014-05-13 16:17:00-04:00,CPIX,neutral
289831.0,Cumberland Announces Vaprisol Promotion ,2014-05-07 07:01:00-04:00,CPIX,neutral
289832.0,Cumberland Pharmaceuticals: Caldolor Study Met Primary Endpoint,2014-03-07 14:05:00-05:00,CPIX,neutral
289833.0,Cumberland Pharmaceuticals Inc. Reports Q4 EPS of $(0.08) vs $0.05 Est; Revenue of $8.16M vs $8.19M Est,2014-03-04 16:06:00-05:00,CPIX,neutral
289834.0,Cumberland Pharmaceuticals Acquires Vaprisol® from Astellas Pharma US; Terms Undisclosed,2014-03-03 08:06:00-05:00,CPIX,neutral
289835.0,Cumberland Pharmaceuticals Inc. Reports Q3 EPS of $(0.04) vs $0.00 Est; Revenue of $6.53M vs $7.60M Est,2013-11-05 16:58:00-05:00,CPIX,neutral
289836.0,Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2013-08-13 05:55:00-04:00,CPIX,negative
289837.0,Cumberland Pharmaceuticals Inc. Reports Q2 EPS of $(0.03) Which May Not Compare $0.02 Est; Revenue of $7.08M Which May Not Compare $9.40M Est,2013-08-06 16:39:00-04:00,CPIX,neutral
289838.0,Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio ,2013-05-17 04:35:00-04:00,CPIX,negative
289839.0,"Cumberland Pharmaceuticals Inc. Reports Q1 EPS of $0.05, Inline; Revenue of $10.30M vs $10.0M Est",2013-05-02 17:03:00-04:00,CPIX,neutral
289840.0,"UBS Maintains Neutral on Cumberland Pharmaceuticals Inc., Raises PT to $5.50",2013-04-10 09:43:00-04:00,CPIX,neutral
289841.0,Cumberland Pharmaceuticals Inc. Reports Q4 EPS of $0.09 vs $0.14 Est; Revenue of $13.70M vs $13.87M Est,2013-02-28 16:27:00-05:00,CPIX,neutral
289842.0,"Cumberland Pharma, PT. SOHO Industri Pharmasi Announce Licensing Deal for Caldolor in Indonesia",2013-01-29 09:42:00-05:00,CPIX,neutral
289843.0,"UBS Maintains Cumberland Pharmaceuticals at Neutral, Lowers PT from $6.50 to $5",2012-11-12 10:49:00-05:00,CPIX,negative
289844.0,Wells Fargo Downgraded Cumberland Pharmaceuticals from Outperform to Market Perform,2012-11-09 10:35:00-05:00,CPIX,positive
289845.0,Benzinga's Top Downgrades,2012-11-09 07:16:00-05:00,CPIX,positive
289846.0,Cumberland Pharmaceuticals Reports Q2 EPS $0.09 vs $0.07 Est; Revenues $12.4M vs $12.65M Est,2012-08-02 16:28:00-04:00,CPIX,neutral
289847.0,"UBS Lowers PT on Cumberland Pharmaceuticals from $8 to $7, Maintains Neutral",2012-06-18 11:11:00-04:00,CPIX,negative
289848.0,"Cumberland Pharma Sues Perrigo, Innopharma Over Patent -Bloomberg",2012-05-18 11:28:00-04:00,CPIX,neutral
289849.0,Cumberland Pharmaceuticals Reports Q1 EPS $0.02 vs $0.05 Est,2012-05-03 17:38:00-04:00,CPIX,neutral
289850.0,Cumberland Pharmaceuticals Reports Q4 EPS $0.04 vs $0.05 Est; Revenues $13M vs $12.97M Est,2012-02-29 16:06:00-05:00,CPIX,neutral
289851.0,Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China,2012-02-28 16:06:00-05:00,CPIX,positive
289852.0,Cumberland Receives Acetadote® Patent Notice of Allowance ,2012-02-08 16:21:00-05:00,CPIX,neutral
289853.0,Cumberland Pharmaceuticals Reports Q3 EPS $0.09 vs $0.06 Est; Revenues $13.10M vs $13.17M Est,2011-11-03 16:21:00-04:00,CPIX,neutral
289854.0,Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin,2011-11-03 07:25:00-04:00,CPIX,positive
289855.0,Cumberland Pharmaceuticals Inks New Bank $10M Financing Deal With Bank of America ,2011-08-04 13:04:00-04:00,CPIX,neutral
289856.0,Duncan-Williams Maintains Hold Rating on Cumberland Pharmaceuticals,2011-06-29 08:02:00-04:00,CPIX,neutral
289857.0,Benzinga's After Hours Decliners ,2011-06-28 18:07:00-04:00,CPIX,neutral
289858.0,Jefferies Maintains Hold Rating On Cumberland Pharmaceuticals (CPIX),2011-05-05 07:45:00-04:00,CPIX,neutral
289859.0,Cumberland Pharmaceuticals Reports Q4 EPS of $0.04 vs. $0.03,2011-03-08 16:12:00-05:00,CPIX,neutral
289860.0,"Earnings Scheduled For March 8 (DMND, SVN, AVAV, BF-B, FMCN, DKS, CKEC, BKCC, CAS, SAM, AHS, CPIX, AREX)",2011-03-08 02:28:00-05:00,CPIX,neutral
289861.0,Jefferies Remains Cautious On Cumberland Pharma ,2011-01-21 09:55:00-05:00,CPIX,negative
289862.0,Cumberland Pharmaceuticals Soars 19.1% On FDA Approval (CPIX),2011-01-14 15:57:00-05:00,CPIX,positive
289863.0,"Borders, Corinithian: Small-Cap Winners",2011-01-14 12:31:00-05:00,CPIX,positive
289864.0,Good News for Cumberland Pharma - Analyst Blog,2011-01-14 11:31:00-05:00,CPIX,positive
289865.0,Good News for Cumberland Pharma - Analyst Blog,2011-01-14 11:00:00-05:00,CPIX,positive
289866.0,Cumberland Pharmaceuticals Jumps 19% (CPIX),2011-01-14 09:20:00-05:00,CPIX,neutral
289867.0,"Benzinga's Top Pre-Market NASDAQ Gainers (CPIX, COCO, ICGN, KLAC)",2011-01-14 08:34:00-05:00,CPIX,positive
289868.0,Jefferies Maintains CPIX Estimates Following Drug Announcement ,2011-01-14 07:47:00-05:00,CPIX,neutral
289869.0,"Intel, Coinstar: After-Hours Trading",2011-01-13 18:51:00-05:00,CPIX,neutral
289870.0,Cumberland Pharmaceuticals New Formulation of Acetadote Receives FDA Approval,2011-01-13 17:07:00-05:00,CPIX,positive
289871.0,Cumberland Pharmaceuticals Appoints Joey Jacobs to Its Board of Directors ,2011-01-06 07:44:00-05:00,CPIX,neutral
289872.0,Recall of Liver Drug by CPIX - Analyst Blog,2011-01-04 10:00:00-05:00,CPIX,neutral
289873.0,Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote Vials ,2010-12-30 16:06:00-05:00,CPIX,neutral
289874.0,Setback for Cumberland Pharma - Analyst Blog,2010-12-27 09:30:00-05:00,CPIX,neutral
289875.0,Cumberland Pharmaceuticals Falls 10.9% On FDA News (CPIX),2010-12-22 16:24:00-05:00,CPIX,neutral
289876.0,FDA Issues Complete Response Letter Regarding Acetadote,2010-12-22 07:38:00-05:00,CPIX,neutral
289877.0,Cumberland Pharmaceuticals FDA Rejection In CRL (CPIX),2010-12-22 07:32:00-05:00,CPIX,negative
289878.0,"Cumberland Pharmaceuticals Posts 30% Placement Increase, Jefferies & Company Reports",2010-11-12 08:02:00-05:00,CPIX,positive
289879.0,Cumberland Pharmaceuticals Reports Third Quarter 2010 Financial Results: EPS of $0.05,2010-11-11 16:18:00-05:00,CPIX,neutral
289880.0,"Tech Stocks Fly, Pharma Stocks Cry! (DELL, HPQ, PAR, CML, CVLT, ISLN, TPL, JAZZ, EPCT, CPIX)",2010-08-23 13:11:00-04:00,CPIX,negative
289881.0,"FDA Delay Causes EpiCept Shares See Red (EPCT, CPIX)",2010-08-23 11:52:00-04:00,CPIX,neutral
289882.0,Cumberland In The Red Due To FDA Delay (CPIX),2010-08-23 11:28:00-04:00,CPIX,negative
289883.0,Wells Fargo Downgrades CPIX To Market Perform,2010-08-17 06:12:00-04:00,CPIX,positive
